The Molecular Evidence Development Consortium (MED-C) is an independent, non-profit consortium dedicated to oncology research.

MED-C’s mission is to accelerate molecular research through leadership, focus, value, quality and access. The organization seeks to help build an infrastructure that will enable molecular medicine to advance through the introduction of disease-specific trials, beginning in oncology. By harnessing the strength of patients, physicians, payors, pharma, laboratories, industry, and regulatory bodies, MED-C plans to rapidly advance oncology field.